- Report
- November 2024
- 79 Pages
Global
From €5563EUR$5,600USD£4,626GBP
- Report
- November 2024
- 89 Pages
Global
From €5563EUR$5,600USD£4,626GBP
- Report
- November 2024
- 86 Pages
Global
From €5563EUR$5,600USD£4,626GBP
- Report
- November 2024
- 94 Pages
Global
From €5563EUR$5,600USD£4,626GBP
- Report
- November 2024
- 184 Pages
Global
From €4918EUR$4,950USD£4,089GBP
- Report
- November 2024
- 187 Pages
Global
From €4918EUR$4,950USD£4,089GBP
- Report
- November 2024
- 312 Pages
Global
From €5414EUR$5,450USD£4,502GBP
- Report
- November 2024
- 263 Pages
Global
From €5414EUR$5,450USD£4,502GBP
- Report
- November 2024
- 184 Pages
Global
From €5414EUR$5,450USD£4,502GBP
- Report
- November 2024
- 167 Pages
Global
From €5414EUR$5,450USD£4,502GBP
- Report
- November 2024
- 164 Pages
Global
From €5414EUR$5,450USD£4,502GBP
- Report
- November 2024
- 146 Pages
Global
From €5414EUR$5,450USD£4,502GBP
- Report
- November 2024
- 191 Pages
Global
From €5563EUR$5,600USD£4,626GBP
- Report
- November 2024
- 456 Pages
Global
From €5414EUR$5,450USD£4,502GBP
- Report
- November 2024
- 213 Pages
Global
From €5414EUR$5,450USD£4,502GBP
- Report
- November 2024
- 93 Pages
Global
From €5563EUR$5,600USD£4,626GBP
- Report
- November 2024
- 78 Pages
Global
From €5563EUR$5,600USD£4,626GBP
- Report
- November 2024
- 93 Pages
Global
From €5563EUR$5,600USD£4,626GBP
- Report
- November 2024
- 322 Pages
Global
From €5414EUR$5,450USD£4,502GBP
- Report
- March 2024
- 221 Pages
Global
From €2434EUR$2,450USD£2,024GBP
The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more